The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
One partner. Every phase. Visit booth 6A2 at CPHI Milan 2026 to streamline drug development.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Building a robust FIH biologics regulatory CMC package
Webinar On Demand
When you enter the clinical trial stage of your molecule’s development, you must prepare a dossier to support conducting the clinical research. A critical component of this dossier is the package of documentation that supports the chemistry, manufacturing, and controls (CMC) of your molecule. A robust CMC package provides health authorities with the information to assess the quality of material entering clinical trials. Inadequate CMC supportive evidence or insufficient detail can delay the go-ahead to enter the clinic. At the same time, unnecessary granularity can impact the lifecycle management of the dossier.
Join us to learn how to develop a robust first-in-human (FIH) regulatory CMC package for recombinant biological molecules by integrating the following activities into your project plan.
- Progressively developing knowledge of the molecule’s critical quality attributes to justify the manufacturing and control strategy
- Planning for continuing development
- Identifying opportunities to enhance with scientific advice